pipette
ESEspañol

Noncanonical CD11b on CD8+ T cells promotes cytotoxic effector function

J. Etxaniz, A. Bosch, E. Prieto, L. Perez Gutierrez, K. Yu, P. Velasco, L. Egia, I. Oyenarte, S. Y. Lee, A. De Blas, I. Eguren Santamaria, J. Jimenez Barbero, M. F. Sanmamed, M. Caffarel, A. M. Aransay, A. Gros, P. Cespedes Donoso, A. Palazon, J. Ereno-Orbea, A. Antonana-Vildosola

Preprint

In the authors' words

Cancer immunosurveillance largely relies on effector CD8+ T cells, yet surface determinants of cytotoxic competence within tumor-reactive populations remain incompletely defined. Using single-cell surface proteomics in a mouse breast cancer model, we identified a tumor-enriched subset of antigen-experienced CD8+ T cells expressing CD11b, a prototypic myeloid integrin. CD11b CD8 T cells were detected across mouse tumor models and human solid tumors and, within tumor-reactive populations, CD11b marked cells with greater cytotoxic potential. Following activation, naive CD8+ T cells induced ITGAM transcription and CD18-dependent CD11b surface expression. Mechanistically, CD11b localized to the peripheral adhesive ring of the immune synapse and promoted lytic-granule secretion. Accordingly, CD11b+ T cells exhibited enhanced TCR- and CAR-mediated tumor cell killing, whereas CD11b deletion impaired T cell antitumor activity. Together, these findings identify CD11b as an inducible, noncanonical component of the T cell immune synapse that marks cytotoxic competence and promotes antitumor T cell function.

Main resultThe abstract does not state a limitation.

Appeared: Thursday, October 15. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.07.757268